Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race
- PMID: 32157445
- DOI: 10.1007/s00467-020-04499-2
Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race
Abstract
Background: Studies investigating bone histology in children with chronic kidney disease (CKD) are scarce.
Methods: Forty-two patients, mean age 11.3 ± 4.3 years with stage 5 CKD on dialysis, underwent double tetracycline labeling bone biopsy and the relationship between clinical features, biochemical markers, and bone densitometry (DXA) was investigated.
Results: Low bone turnover was present in 59% of patients, abnormal mineralization in 29%, and low bone volume in 7%. Higher bone formation rate was found in non-Caucasian patients, whereas abnormal mineralization occurred in older and shorter children. We found no impact of gender and etiology of renal disease in our population. Parathormone (PTH) and alkaline phosphatase (AP) showed positive associations with bone turnover. ROC curve analysis showed a fair performance of biomarkers to predict TMV status. PTH < 2 times ULN independently associated with low bone turnover (RR 5.62, 95% CI 1.01-31.24; p = 0.049), in a model adjusted for race, calcitriol dosage, and calcium. It was also associated with abnormal mineralization (RR 1.35, 95% CI 1.04-1.75; p = 0.025), in a model adjusted for BMD scores, AP, age, and calcitriol. PTH and AP significantly predicted turnover and mineralization defect, although with low specificity and sensitivity, reaching a maximum value of 64% and 67%, respectively.
Conclusions: While PTH and AP were associated with turnover and mineralization, we recognize the limitation of their performance to clearly distinguish high from low/normal bone turnover and normal from abnormal mineralization. Our results reinforce the need to expand knowledge about renal osteodystrophy in pediatric population through prospective bone biopsy studies. Graphical abstract.
Keywords: Bone biopsy; Bone diseases; Children; Chronic kidney disease; Histomorphometry; Metabolic; Renal osteodystrophy.
Similar articles
-
Value of the new bone classification system in pediatric renal osteodystrophy.Clin J Am Soc Nephrol. 2010 Oct;5(10):1860-6. doi: 10.2215/CJN.01330210. Epub 2010 Jul 15. Clin J Am Soc Nephrol. 2010. PMID: 20634327 Free PMC article.
-
Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.Am J Kidney Dis. 2015 Jul;66(1):99-105. doi: 10.1053/j.ajkd.2015.02.323. Epub 2015 Apr 2. Am J Kidney Dis. 2015. PMID: 25843703 Free PMC article.
-
Bone histomorphometry and indicators of bone and mineral metabolism in wait-listed dialysis patients.Clin Nephrol. 2016 Mar;85(3):127-34. doi: 10.5414/CN108709. Clin Nephrol. 2016. PMID: 26833298
-
Bone disease in pediatric chronic kidney disease.Pediatr Nephrol. 2013 Apr;28(4):569-76. doi: 10.1007/s00467-012-2324-4. Epub 2012 Oct 14. Pediatr Nephrol. 2013. PMID: 23064662 Free PMC article. Review.
-
Adynamic bone disease: from bone to vessels in chronic kidney disease.Semin Nephrol. 2014 Nov;34(6):626-40. doi: 10.1016/j.semnephrol.2014.09.008. Semin Nephrol. 2014. PMID: 25498381 Review.
Cited by
-
Effects of Primary Kidney Disease Etiology on Renal Osteodystrophy in Pediatric Dialysis Patients.JBMR Plus. 2022 Apr 8;6(4):e10601. doi: 10.1002/jbm4.10601. eCollection 2022 Apr. JBMR Plus. 2022. PMID: 35434448 Free PMC article.
-
Adynamic bone disorder in chronic kidney disease: meta-analysis and narrative review of potential biomarkers as diagnosis and therapeutic targets.Ren Fail. 2025 Dec;47(1):2530162. doi: 10.1080/0886022X.2025.2530162. Epub 2025 Jul 16. Ren Fail. 2025. PMID: 40669844 Free PMC article. Review.
-
Bone and Mineral Disorder in Renal Transplant Patients: Overview of Pathology, Clinical, and Therapeutic Aspects.Front Med (Lausanne). 2022 Mar 10;9:821884. doi: 10.3389/fmed.2022.821884. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35360722 Free PMC article. Review.
-
Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular Signaling.Int J Mol Sci. 2021 Jun 18;22(12):6563. doi: 10.3390/ijms22126563. Int J Mol Sci. 2021. PMID: 34207309 Free PMC article.
-
Chronic kidney disease mineral bone disorder in childhood and young adulthood: a 'growing' understanding.Pediatr Nephrol. 2024 Mar;39(3):723-739. doi: 10.1007/s00467-023-06109-3. Epub 2023 Aug 25. Pediatr Nephrol. 2024. PMID: 37624528 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical